Tirzepatide 5 Peptide Plus US
Shipping Details
Your order will be delivered to you within 4-5 business days after your payment is confirmed.
- Brand: Peptide Plus USA
⚠️ WARNING: Potential Risks of Anabolic Steroids
Anabolic steroids can cause hormonal imbalances, liver strain, cardiovascular issues, and psychological effects, and should only be used under strict medical supervision. Unauthorized or improper use may lead to serious health complications.
If used, obtain these substances exclusively from licensed, verified medical providers to ensure safety and proper oversight.
Tirzepatide 5 – Peptide Plus USA (Dual GIP & GLP-1 Receptor Agonist, 5mg Vial)
Product Description:
Tirzepatide 5 by Peptide Plus USA is an equal pharma quality injectable peptide supplied in a 5mg sterile vial. As a dual GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor agonist, Tirzepatide has gained recognition for its ability to regulate blood glucose, promote weight loss, and improve metabolic health.
Originally developed for the treatment of type 2 diabetes, Tirzepatide is now widely studied and used for its fat-burning, appetite-suppressing, and cardiometabolic benefits, making it an innovative solution for both diabetic and non-diabetic users seeking metabolic improvement and weight management.
Key Features
Active Ingredient: Tirzepatide (GIP & GLP-1 receptor agonist)
Strength: 5mg per vial
Pack Size: 1 Vial
Form: Injectable peptide (subcutaneous)
Manufacturer: Peptide Plus USA
What is Tirzepatide (GIP & GLP-1 Receptor Agonist)?
Tirzepatide is a novel dual-action peptide that activates both GIP and GLP-1 receptors. These two incretin hormones regulate insulin secretion, glucagon inhibition, appetite suppression, and fat metabolism.
By combining these mechanisms, Tirzepatide:
Improves blood glucose control in diabetics.
Promotes weight loss and appetite reduction.
Enhances metabolic flexibility for both diabetic and non-diabetic individuals.
Benefits of Tirzepatide 5 (Peptide Plus USA)
Regulates blood sugar – stimulates insulin release, reduces glucagon secretion.
Supports weight loss – suppresses appetite and improves fat metabolism.
Improves cardiovascular health – lowers cholesterol and blood pressure.
Anti-inflammatory activity – may help reduce risks in chronic inflammation-related conditions.
Dual incretin action – more effective than single GLP-1 agonists for metabolic improvement.
Dosage and Administration
Typical Dose: Start low and titrate up based on glucose response and tolerance.
Recommended Use: Once weekly injection.
Administration: Subcutaneous (stomach, thigh, or upper arm).
Monitoring: Blood glucose and side effects should be monitored regularly.
Clinical follow-up is strongly recommended when using Tirzepatide to optimize dosing and manage potential side effects.
Also Known As
Tirzepatide
GIP & GLP-1 Receptor Agonist
Possible Side Effects
Like other GLP-1 receptor agonists, Tirzepatide may cause:
Nausea or digestive discomfort (dose-dependent).
Risk of hypoglycemia when combined with strict dieting or other medications.
Mild headaches or fatigue.
Rare cases of gallbladder stress (with rapid weight loss).
